Finance

Beta
Lists
688606:SHA
Hangzhou Alltest Biotech Co Ltd
CN¥47.55
-1.82%
(-0.88) 1D
Jun 11, 10:25:17 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688606...
Open
CN¥48.43
High
CN¥48.43
Low
CN¥47.52
Mkt. cap
3.88B
Avg. vol.
543.61K
Volume
56.01K
Dividend
4.21%
Quarterly dividend
CN¥0.50
Ex-dividend date
Jun 1, 2026
P/E ratio
21.12
52-wk high
CN¥78.20
52-wk low
CN¥46.53
EPS
CN¥2.25
No. of employees
992
Open
CN¥48.43
High
CN¥48.43
Low
CN¥47.52
Mkt. cap
3.88B
Avg. vol.
543.61K
Volume
56.01K
Dividend
4.21%
Quarterly dividend
CN¥0.50
Ex-dividend date
Jun 1, 2026
P/E ratio
21.12
52-wk high
CN¥78.20
52-wk low
CN¥46.53
EPS
CN¥2.25
No. of employees
992
News stories
From sources across the web
About Hangzhou Alltest Biotech Co Ltd
CEO-
Employees992
FoundedApr 17, 2009
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
221.37M
203.23M
272.27M
195.37M
Cost of goods sold
95.03M
89.68M
171.15M
91.99M
Cost of revenue
95.03M
89.68M
171.15M
91.99M
Research and development expenses
27.04M
26.02M
35.10M
28.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.99M
41.16M
44.86M
36.47M
Operating expense
73.76M
47.19M
103.62M
73.22M
Total operating expenses
168.79M
136.87M
274.76M
165.21M
Operating income
52.58M
66.36M
-2.49M
30.17M
Other non operating income
-954.17K
-4.55M
3.58M
-19.03M
EBT including unusual items
87.59M
66.14M
32.93M
21.76M
EBT excluding unusual items
68.95M
68.37M
-12.92M
16.13M
Income tax expense
16.66M
8.52M
2.58M
2.63M
Effective tax rate
19.03%
12.88%
7.84%
12.08%
Other operating expenses
2.21M
-22.23M
27.73M
4.68M
Net income
70.80M
57.80M
30.38M
19.39M
Net profit margin
31.98%
28.44%
11.16%
9.93%
Earnings per share
-
-
-
-
Interest and investment income
16.85M
7.19M
-
5.20M
Interest expense
-21.74K
-147.09K
-1.06M
-206.80K
Net interest expenses
16.83M
7.05M
-1.06M
5.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
59.76M
72.82M
7.39M
40.05M
Gain or loss from assets sale
-
-
-616.68K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more